Executives from Airbus, AstraZeneca and HSBC are joining Prime Minister Keir Starmer on a rare China visit, highlighting the business focus of the trip amid strained global trade relations.

Keir Starmer spent around three hours with the Chinese President, who rolled out the red carpet with a lavish banquet and a ceremonial welcome at Beijing’s Great Hall of the People

U.K. Prime Minister Keir Starmer visits Beijing for a four-day visit to China aimed at repairing ties and expanding opportunities for British businesses in the world’s second-largest economy.

By Andrew MacAskill and Maggie Fick BEIJING/LONDON, Jan 29 (Reuters) - UK drugmaker AstraZeneca will invest $15 billion in China through 2030 to expand medicines manufacturing and research and development,

Prime Minister Keir Starmer said the UK wouldn’t have to choose between the US and China, as he heralded “significant opportunities” for British businesses ahead of his trip to Beijing this week.

Pathway to a coup ‘still unclear’ even as potential challengers begin manoeuvring into position

Starmer - who is travelling with around 60 British business and cultural leaders - is the first UK prime minister to visit China since 2018.

As London dispatches Prime Minister Keir Starmer to Beijing with a business entourage, vowing a "clear-eyed" approach to national security, the symbolism is hard to miss. Europe is hedging: away from American tech, not necessarily toward Chinese tech—but toward strategic room to maneuver if Washington under President Donald Trump turns hostile.